finasteride Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definition	Drug id	CAS RN
testosterone reductase inhibitors	1171	98319-26-7

Description:

Molecule	Description
Molfile Inchi Smiles Synonyms: finasteride finastid prosteride prostide propecia	An orally active 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE inhibitor. It is used as a surgical alternative for treatment of benign PROSTATIC HYPERPLASIA. Molecular weight: 372.55 Formula: C23H36N2O2 CLOGP: 3.01 LIPINSKI: 0 HAC: 4 HDO: 2 TPSA: 58.20 ALOGS: -5.27 ROTB: 2 Status: OFP Legend: OFP - off patent OFM - off market ONP - on patent

Molecule

Description

Molfile Inchi Smiles

Synonyms:

finasteride
finastid
prosteride
prostide
propecia

An orally active 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE inhibitor. It is used as a surgical alternative for treatment of benign PROSTATIC HYPERPLASIA.

Molecular weight: 372.55
Formula: C23H36N2O2
CLOGP: 3.01
LIPINSKI: 0
HAC: 4
HDO: 2
TPSA: 58.20
ALOGS: -5.27
ROTB: 2

Status: OFP

Legend:
OFP - off patent
OFM - off market
ONP - on patent

Drug dosage:

Dose	Unit	Route
1	mg	O
5	mg	O

ADMET properties:

Property	Value	Reference
BDDCS (Biopharmaceutical Drug Disposition Classification System)	1	Benet LZ, Broccatelli F, Oprea TI
S (Water solubility)	0.04 mg/mL	Benet LZ, Broccatelli F, Oprea TI
EoM (Fraction excreted unchanged in urine)	0.50 %	Benet LZ, Broccatelli F, Oprea TI
MRTD (Maximum Recommended Therapeutic Daily Dose)	0.19 µM/kg/day	Contrera JF, Matthews EJ, Kruhlak NL, Benz RD
BA (Bioavailability)	63 %	Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H
Vd (Volume of distribution)	1.10 L/kg	Lombardo F, Berellini G, Obach RS
CL (Clearance)	2.40 mL/min/kg	Lombardo F, Berellini G, Obach RS
fu (Fraction unbound in plasma)	0.10 %	Lombardo F, Berellini G, Obach RS
t_half (Half-life)	6 hours	Lombardo F, Berellini G, Obach RS

Approvals:

Date	Agency	Company	Orphan
June 19, 1992	FDA	MERCK

FDA Adverse Event Reporting System (Female)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Exposure via body fluid	267.57	244.92	31	110	247	2357697

FDA Adverse Event Reporting System (Male)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Erectile dysfunction	5678.59	52.37	960	1731	3537	1740553
Sexual dysfunction	5566.83	52.37	837	1854	986	1743104
Depression	2876.27	52.37	684	2007	15985	1728105
Libido decreased	2701.27	52.37	434	2257	891	1743199
Anxiety	2560.42	52.37	616	2075	14911	1729179
Cognitive disorder	2441.56	52.37	475	2216	3855	1740235
Loss of libido	2161.67	52.37	331	2360	397	1743693
Ejaculation disorder	1442.40	52.37	222	2469	272	1743818
Semen volume decreased	1356.50	52.37	193	2498	58	1744032
Gynaecomastia	1033.57	52.37	208	2483	1924	1742166
Hypogonadism	960.50	52.37	149	2542	195	1743895
Ejaculation failure	956.91	52.37	151	2540	238	1743852
Testicular pain	898.94	52.37	156	2535	559	1743531
Blood testosterone decreased	890.24	52.37	164	2527	888	1743202
Penile size reduced	703.21	52.37	103	2588	58	1744032
Organic erectile dysfunction	639.35	52.37	92	2599	35	1744055
Hormone level abnormal	633.66	52.37	96	2595	92	1743998
Insomnia	570.79	52.37	197	2494	16079	1728011
Fatigue	564.39	52.37	268	2423	50513	1693577
Product administration error	561.76	52.37	134	2557	2819	1741271
Penis injury	492.42	52.37	71	2620	28	1744062
Testicular atrophy	485.25	52.37	76	2615	108	1743982
Suicidal ideation	467.32	52.37	145	2546	8373	1735717
Peyronie's disease	434.23	52.37	70	2621	133	1743957
Brain injury	429.35	52.37	89	2602	942	1743148
Testicular disorder	392.81	52.37	64	2627	134	1743956
Benign prostatic hyperplasia	380.30	52.37	85	2606	1313	1742777
Hyperlipidaemia	376.29	52.37	92	2599	2137	1741953
Prostatitis	370.05	52.37	78	2613	899	1743191
Varicocele	363.20	52.37	53	2638	27	1744063
Disturbance in attention	353.79	52.37	100	2591	4134	1739956
Panic attack	351.32	52.37	84	2607	1768	1742322
Wrong technique in product usage process	350.36	52.37	123	2568	10412	1733678
Hypertension	350.31	52.37	145	2546	19303	1724787
Penis disorder	345.47	52.37	63	2628	312	1743778
Painful ejaculation	340.59	52.37	49	2642	18	1744072
Genital hypoaesthesia	340.39	52.37	51	2640	41	1744049
Emotional distress	319.31	52.37	78	2613	1800	1742290
Gastrooesophageal reflux disease	318.06	52.37	94	2597	4553	1739537
Endocrine disorder	289.15	52.37	45	2646	59	1744031
Back pain	285.70	52.37	120	2571	16493	1727597
Stress	283.41	52.37	76	2615	2565	1741525
Testicular failure	277.74	52.37	40	2651	15	1744075
Hypogonadism male	276.44	52.37	43	2648	56	1744034
Nocturia	274.48	52.37	63	2628	1098	1742992
Dysuria	258.62	52.37	76	2615	3596	1740494
Alopecia	243.90	52.37	73	2618	3680	1740410
Male orgasmic disorder	239.24	52.37	37	2654	45	1744045
Orgasm abnormal	238.35	52.37	37	2654	47	1744043
Muscle atrophy	235.74	52.37	56	2635	1139	1742951
Feeling abnormal	233.79	52.37	93	2598	11073	1733017
Epididymal cyst	226.56	52.37	33	2658	16	1744074
Sleep apnoea syndrome	226.33	52.37	61	2630	2093	1741997
Major depression	224.88	52.37	49	2642	664	1743426
Amnesia	224.85	52.37	73	2618	4818	1739272
Asthenia	223.23	52.37	128	2563	34542	1709548
Headache	221.55	52.37	127	2564	34249	1709841
Drug ineffective	216.12	52.37	157	2534	63644	1680446
Androgen deficiency	208.78	52.37	33	2658	51	1744039
Pollakiuria	207.44	52.37	61	2630	2885	1741205
Anorgasmia	205.91	52.37	37	2654	165	1743925
Arthralgia	201.75	52.37	105	2586	23339	1720751
Hair transplant	200.42	52.37	28	2663	3	1744087
Attention deficit/hyperactivity disorder	197.16	52.37	41	2650	437	1743653
Semen analysis abnormal	196.54	52.37	29	2662	18	1744072
Sleep disorder	192.20	52.37	62	2629	4001	1740089
Infertility male	187.33	52.37	33	2658	128	1743962
Adverse event	183.74	52.37	62	2629	4606	1739484
Sperm concentration decreased	182.62	52.37	31	2660	91	1743999
Urine flow decreased	180.68	52.37	35	2656	251	1743839
Hypercholesterolaemia	178.93	52.37	45	2646	1167	1742923
Melanocytic naevus	177.93	52.37	37	2654	394	1743696
Male reproductive tract disorder	173.57	52.37	27	2664	35	1744055
Memory impairment	173.06	52.37	65	2626	6598	1737492
Infertility	166.33	52.37	30	2661	137	1743953
Penile pain	164.91	52.37	33	2658	285	1743805
Premature ejaculation	163.82	52.37	27	2664	62	1744028
Dizziness	159.37	52.37	103	2588	34258	1709832
Prostate cancer	156.96	52.37	55	2636	4571	1739519
Weight increased	155.36	52.37	70	2621	11287	1732803
Blood cholesterol increased	154.64	52.37	49	2642	2977	1741113
Palpitations	153.72	52.37	60	2631	6754	1737336
Tonsillectomy	153.19	52.37	27	2664	105	1743985
Epididymitis	152.09	52.37	32	2659	362	1743728
Haemorrhoids	151.67	52.37	43	2648	1778	1742312
Vitamin D deficiency	149.89	52.37	33	2658	469	1743621
Tinnitus	139.83	52.37	46	2645	3149	1740941
Generalised anxiety disorder	139.72	52.37	25	2666	108	1743982
Knee operation	138.52	52.37	30	2661	393	1743697
Acne	138.49	52.37	40	2651	1768	1742322
Orgasmic sensation decreased	138.38	52.37	21	2670	20	1744070
Reproductive tract disorder	137.73	52.37	20	2671	9	1744081
Breast enlargement	135.42	52.37	25	2666	133	1743957
Apathy	132.72	52.37	36	2655	1260	1742830
Hydrocele	131.69	52.37	28	2663	334	1743756
Rhinitis allergic	130.56	52.37	28	2663	349	1743741
Urinary retention	130.50	52.37	50	2641	5345	1738745
Male genital atrophy	127.87	52.37	18	2673	3	1744087
Hypoaesthesia	126.15	52.37	58	2633	9777	1734313
Vasectomy	123.29	52.37	19	2672	22	1744068
Azoospermia	122.67	52.37	24	2667	182	1743908
Road traffic accident	122.66	52.37	43	2648	3570	1740520
Haematuria	120.73	52.37	52	2639	7508	1736582
Osteoarthritis	120.67	52.37	38	2653	2258	1741832
Prostatomegaly	119.51	52.37	29	2662	644	1743446
Muscle strain	118.31	52.37	28	2663	557	1743533
Chest pain	118.22	52.37	70	2621	19844	1724246
Male sexual dysfunction	117.21	52.37	20	2671	61	1744029
Hypothyroidism	116.60	52.37	38	2653	2522	1741568
Back injury	115.98	52.37	28	2663	608	1743482
Groin pain	115.37	52.37	29	2662	748	1743342
Vision blurred	115.33	52.37	52	2639	8371	1735719
Joint injury	114.95	52.37	31	2660	1060	1743030
Breast tenderness	114.15	52.37	23	2668	206	1743884
Dry skin	113.95	52.37	41	2650	3671	1740419
Pain	113.79	52.37	76	2615	26581	1717509
Intervertebral disc protrusion	113.74	52.37	33	2658	1480	1742610
Disturbance in sexual arousal	113.40	52.37	20	2671	78	1744012
Eczema	111.96	52.37	36	2655	2288	1741802
Breast mass	111.06	52.37	22	2669	179	1743911
Upper respiratory tract infection	110.04	52.37	41	2650	4052	1740038
Myalgia	108.77	52.37	61	2630	15597	1728493
Ligament sprain	108.51	52.37	25	2666	440	1743650
Nephrolithiasis	107.36	52.37	40	2651	3952	1740138
Essential hypertension	107.05	52.37	23	2668	289	1743801
Lower urinary tract symptoms	107.00	52.37	18	2673	49	1744041
Neck pain	106.41	52.37	38	2653	3328	1740762
Obesity	105.93	52.37	29	2662	1050	1743040
Irritable bowel syndrome	103.76	52.37	25	2666	538	1743552
Hernia repair	102.87	52.37	22	2669	270	1743820
Asthma	95.92	52.37	39	2652	4865	1739225
Spermatocele	94.06	52.37	14	2677	10	1744080
Skin disorder	94.00	52.37	31	2660	2133	1741957
Anogenital warts	93.62	52.37	18	2673	123	1743967
Dyspepsia	91.90	52.37	38	2653	4947	1739143
Emotional disorder	91.37	52.37	26	2665	1086	1743004
Stress at work	91.20	52.37	16	2675	60	1744030
Seborrhoeic dermatitis	91.16	52.37	19	2672	204	1743886
Wisdom teeth removal	89.80	52.37	16	2675	67	1744023
Perineal pain	89.80	52.37	16	2675	67	1744023
Dermal cyst	89.69	52.37	19	2672	222	1743868
Prostatic specific antigen increased	89.06	52.37	31	2660	2515	1741575
Prostatic pain	88.58	52.37	15	2676	43	1744047
Muscle spasms	88.11	52.37	48	2643	11573	1732517
Secondary hypogonadism	87.98	52.37	16	2675	77	1744013
Dihydrotestosterone decreased	87.08	52.37	12	2679	0	1744090
Adverse drug reaction	86.94	52.37	36	2655	4702	1739388
Soft tissue injury	86.88	52.37	15	2676	50	1744040
Oligospermia	86.23	52.37	14	2677	28	1744062
Penile curvature	85.90	52.37	14	2677	29	1744061
Lipoma	85.74	52.37	19	2672	278	1743812
Completed suicide	85.51	52.37	53	2638	16259	1727831
Granulomatous rosacea	85.23	52.37	12	2679	2	1744088
Sensory loss	84.88	52.37	23	2668	800	1743290
Dyslipidaemia	84.82	52.37	23	2668	802	1743288
Rash	84.45	52.37	74	2617	38619	1705471
Paraesthesia	84.34	52.37	45	2646	10406	1733684
Self esteem decreased	84.18	52.37	17	2674	154	1743936
Renal cyst	84.02	52.37	24	2667	1016	1743074
Nasal septum deviation	83.59	52.37	17	2674	160	1743930
Social anxiety disorder	83.21	52.37	15	2676	68	1744022
Haematospermia	81.91	52.37	16	2675	120	1743970
Panic disorder	81.37	52.37	18	2673	261	1743829
Marital problem	81.01	52.37	14	2677	47	1744043
Skin papilloma	80.68	52.37	19	2672	369	1743721
Sinusitis	80.28	52.37	35	2656	5188	1738902
Anhedonia	80.27	52.37	22	2669	799	1743291
Fall	80.18	52.37	62	2629	27152	1716938
Anger	80.10	52.37	29	2662	2637	1741453
Genital atrophy	79.82	52.37	11	2680	0	1744090
Post-traumatic stress disorder	79.66	52.37	18	2673	289	1743801
Orchitis	78.64	52.37	18	2673	307	1743783
Pelvic pain	78.09	52.37	18	2673	317	1743773
Shoulder operation	78.08	52.37	17	2674	228	1743862
Micturition urgency	77.22	52.37	21	2670	740	1743350
Weight decreased	76.23	52.37	56	2635	22697	1721393
Intervertebral disc degeneration	75.98	52.37	20	2671	621	1743469
Arthritis	75.61	52.37	31	2660	3944	1740146
Irritability	75.15	52.37	34	2657	5498	1738592
Blood oestrogen increased	74.24	52.37	12	2679	23	1744067
Breast pain	73.51	52.37	17	2674	304	1743786
Arthroscopy	73.43	52.37	13	2678	52	1744038
Arterial insufficiency	72.06	52.37	12	2679	30	1744060
Oestrogen receptor positive breast cancer	71.61	52.37	10	2681	1	1744089
Malaise	71.46	52.37	60	2631	29505	1714585
Hernia	71.09	52.37	22	2669	1230	1742860
Surgery	70.81	52.37	27	2664	2836	1741254
Temperature intolerance	70.75	52.37	18	2673	487	1743603
Seasonal allergy	69.88	52.37	19	2672	669	1743421
Skin laceration	69.04	52.37	24	2667	1937	1742153
Migraine	68.90	52.37	25	2666	2286	1741804
Urinary tract infection	68.89	52.37	39	2652	10114	1733976
Mood swings	68.55	52.37	24	2667	1978	1742112
Dark circles under eyes	68.19	52.37	12	2679	46	1744044
Dry eye	67.57	52.37	21	2670	1191	1742899
Skin atrophy	67.54	52.37	16	2675	319	1743771
Testicular cyst	67.10	52.37	11	2680	24	1744066
Appendicectomy	66.19	52.37	15	2676	244	1743846
Inguinal hernia	65.71	52.37	20	2671	1057	1743033
Genital pain	65.27	52.37	12	2679	62	1744028
Cholecystectomy	65.26	52.37	17	2674	506	1743584
Mental impairment	65.06	52.37	23	2668	1950	1742140
Partner stress	64.48	52.37	12	2679	67	1744023
Inguinal hernia repair	64.48	52.37	12	2679	67	1744023
Mental disorder	63.86	52.37	25	2666	2818	1741272
Soft tissue mass	63.62	52.37	11	2680	37	1744053
Emotional poverty	63.61	52.37	12	2679	73	1744017
Bipolar disorder	63.41	52.37	18	2673	744	1743346
Psychosexual disorder	63.40	52.37	11	2680	38	1744052
Diverticulum	62.74	52.37	19	2672	987	1743103
Somatic symptom disorder	62.24	52.37	13	2678	141	1743949
Libido disorder	62.15	52.37	12	2679	84	1744006
Ejaculation delayed	62.02	52.37	12	2679	85	1744005
Cerumen impaction	60.85	52.37	12	2679	95	1743995
Chronic fatigue syndrome	60.63	52.37	12	2679	97	1743993
Breast cancer male	60.41	52.37	12	2679	99	1743991
Acrochordon	60.30	52.37	12	2679	100	1743990
Limb operation	60.22	52.37	13	2678	167	1743923
Anxiety disorder	60.13	52.37	14	2677	258	1743832
Rotator cuff syndrome	59.97	52.37	18	2673	907	1743183
Varicose vein	59.93	52.37	14	2677	262	1743828
Mood altered	59.71	52.37	22	2669	2100	1741990
Urinary tract obstruction	59.52	52.37	16	2675	539	1743551
Body fat disorder	59.49	52.37	10	2681	27	1744063
Lymphadenectomy	59.32	52.37	11	2680	60	1744030
Blood testosterone increased	59.19	52.37	14	2677	277	1743813
Depressed mood	58.98	52.37	24	2667	2992	1741098
Hepatic function abnormal	58.54	52.37	31	2660	7043	1737047
Pain in extremity	58.53	52.37	44	2647	18428	1725662
Spinal osteoarthritis	58.43	52.37	17	2674	768	1743322
Sexually transmitted disease	57.26	52.37	9	2682	13	1744077
Bronchitis	57.16	52.37	28	2663	5404	1738686
Scrotal pain	56.11	52.37	12	2679	147	1743943
Prostatic disorder	55.95	52.37	15	2676	500	1743590
Seborrhoeic keratosis	55.89	52.37	12	2679	150	1743940
Herpes simplex	55.77	52.37	16	2675	687	1743403
Affective disorder	55.44	52.37	16	2675	702	1743388
Nasal septal operation	55.42	52.37	9	2682	18	1744072
Muscular weakness	55.40	52.37	34	2657	10215	1733875
Testis cancer	54.64	52.37	13	2678	264	1743826
Rotator cuff repair	54.22	52.37	11	2680	102	1743988
Ventricular extrasystoles	54.21	52.37	20	2671	1916	1742174
Urinary tract disorder	54.05	52.37	14	2677	407	1743683
Alcohol abuse	53.75	52.37	15	2676	582	1743508
Sensory disturbance	53.61	52.37	18	2673	1306	1742784
Terminal dribbling	53.57	52.37	8	2683	6	1744084
Adjustment disorder	53.47	52.37	11	2680	110	1743980
Radical prostatectomy	53.09	52.37	9	2682	26	1744064
Rosacea	52.96	52.37	12	2679	195	1743895
Onychomycosis	52.78	52.37	13	2678	307	1743783
Limb injury	52.75	52.37	18	2673	1372	1742718
Abdominal pain	52.64	52.37	44	2647	21446	1722644
Lethargy	52.52	52.37	29	2662	7155	1736935
Skin lesion	52.52	52.37	22	2669	2950	1741140

Pharmacologic Action:

Source	Code	Description
ATC	D11AX10	DERMATOLOGICALS OTHER DERMATOLOGICAL PREPARATIONS OTHER DERMATOLOGICAL PREPARATIONS Other dermatologicals
ATC	G04CA51	GENITO URINARY SYSTEM AND SEX HORMONES UROLOGICALS DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY Alpha-adrenoreceptor antagonists
ATC	G04CB01	GENITO URINARY SYSTEM AND SEX HORMONES UROLOGICALS DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY Testosterone-5-alpha reductase inhibitors
MeSH PA	D058891	5-alpha Reductase Inhibitors
FDA EPC	N0000175836	5-alpha Reductase Inhibitor
MeSH PA	D004791	Enzyme Inhibitors
MeSH PA	D006727	Hormone Antagonists
CHEBI has role	CHEBI:59844	antihyperplasia drug
CHEBI has role	CHEBI:35497	androgen antagonist
MeSH PA	D065088	Steroid Synthesis Inhibitors
MeSH PA	D064804	Urological Agents

Drug Use (View source of the data)

Disease	Relation	SNOMED_ID	DOID
Benign prostatic hyperplasia	indication	266569009
Male Patterned Baldness	indication
Disease of liver	contraindication	235856003	DOID:409
Pregnancy, function	contraindication	289908002
Breastfeeding (mother)	contraindication	413712001
High-Grade Prostate Cancer	contraindication
Breast Carcinoma in Males	contraindication

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation level	Dissociation constant	Type (acidic/basic)
pKa1	13.26	acidic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

Target	Class	Pharos	UniProt	Action	Type	Activity value (-log[M])	Bioact source	MoA source
3-oxo-5-alpha-steroid 4-dehydrogenase 1	Enzyme	P18405	S5A1_HUMAN	INHIBITOR	IC50	7.58	WOMBAT-PK	DRUG LABEL
3-oxo-5-alpha-steroid 4-dehydrogenase 2	Enzyme	P31213	S5A2_HUMAN	INHIBITOR	IC50	8.26	WOMBAT-PK	DRUG LABEL
Cytochrome P450 2C19	Enzyme	P33261	CP2CJ_HUMAN		IC50	6	DRUG MATRIX
3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1	Enzyme	P14060	3BHS1_HUMAN		Ki	4.96	CHEMBL
Cytochrome P450 2C9	Enzyme	P11712	CP2C9_HUMAN		IC50	5.70	DRUG MATRIX
3-oxo-5-alpha-steroid 4-dehydrogenase 1	Enzyme		S5A1_RAT		Ki	8.17	CHEMBL
3-oxo-5-alpha-steroid 4-dehydrogenase 2	Enzyme		S5A2_RAT		IC50	9.55	CHEMBL
Steroid 5-alpha-reductase	Enzyme		S5A1_RAT S5A2_RAT		Ki	7.26	CHEMBL

External reference:

ID	Source
4020167	VUID
N0000148118	NUI
C0060389	UMLSCUI
D00321	KEGG_DRUG
57GNO57U7G	UNII
6539	INN_ID
109035006	SNOMEDCT_US
4020167	VANDF
82773	MMSL
003665	NDDF
25025	RXNORM
386963006	SNOMEDCT_US
4728	MMSL
d00563	MMSL
CHEMBL710	ChEMBL_ID
FIT	PDB_CHEM_ID
DB01216	DRUGBANK_ID
CHEBI:5062	CHEBI
D018120	MESH_DESCRIPTOR_UI
57363	PUBCHEM_CID
6818	IUPHAR_LIGAND_ID

Pharmaceutical products:

Product	Category	Ingredients	NDC	Form	Quantity	Route	Marketing	Label
PROPECIA	HUMAN PRESCRIPTION DRUG LABEL	1	0006-0071	TABLET, FILM COATED	1 mg	ORAL	NDA	18 sections
PROSCAR	HUMAN PRESCRIPTION DRUG LABEL	1	0006-0072	TABLET, FILM COATED	5 mg	ORAL	NDA	18 sections
Finasteride	HUMAN PRESCRIPTION DRUG LABEL	1	0093-7355	TABLET, FILM COATED	5 mg	ORAL	ANDA	16 sections
Finasteride	HUMAN PRESCRIPTION DRUG LABEL	1	0179-0175	TABLET	5 mg	ORAL	ANDA	19 sections
Finasteride	HUMAN PRESCRIPTION DRUG LABEL	1	0904-6830	TABLET, FILM COATED	5 mg	ORAL	ANDA	17 sections
Finasteride	HUMAN PRESCRIPTION DRUG LABEL	1	16729-089	TABLET, FILM COATED	1 mg	ORAL	ANDA	18 sections
Finasteride	HUMAN PRESCRIPTION DRUG LABEL	1	16729-090	TABLET, FILM COATED	5 mg	ORAL	ANDA	17 sections
Finasteride	HUMAN PRESCRIPTION DRUG LABEL	1	17856-0090	TABLET, FILM COATED	5 mg	ORAL	ANDA	17 sections
Finasteride	HUMAN PRESCRIPTION DRUG LABEL	1	31722-525	TABLET, FILM COATED	5 mg	ORAL	ANDA	11 sections
Finasteride	HUMAN PRESCRIPTION DRUG LABEL	1	31722-526	TABLET, FILM COATED	1 mg	ORAL	ANDA	17 sections
Finasteride	HUMAN PRESCRIPTION DRUG LABEL	1	33261-833	TABLET	5 mg	ORAL	ANDA	18 sections
Finasteride	HUMAN PRESCRIPTION DRUG LABEL	1	35573-400	TABLET, FILM COATED	1 mg	ORAL	ANDA	17 sections
Finasteride	HUMAN PRESCRIPTION DRUG LABEL	1	42291-280	TABLET, FILM COATED	5 mg	ORAL	ANDA	18 sections
Finasteride	HUMAN PRESCRIPTION DRUG LABEL	1	43598-303	TABLET, FILM COATED	5 mg	ORAL	ANDA	17 sections
Finasteride	HUMAN PRESCRIPTION DRUG LABEL	1	43598-390	TABLET, FILM COATED	1 mg	ORAL	ANDA	17 sections
Finasteride	HUMAN PRESCRIPTION DRUG LABEL	1	50090-1718	TABLET, FILM COATED	5 mg	ORAL	ANDA	17 sections
Finasteride	HUMAN PRESCRIPTION DRUG LABEL	1	50090-3942	TABLET, FILM COATED	1 mg	ORAL	ANDA	18 sections
Finasteride	HUMAN PRESCRIPTION DRUG LABEL	1	50090-4648	TABLET, COATED	1 mg	ORAL	ANDA	17 sections
Finasteride	HUMAN PRESCRIPTION DRUG LABEL	1	50090-4697	TABLET, FILM COATED	5 mg	ORAL	ANDA	16 sections
Finasteride	HUMAN PRESCRIPTION DRUG LABEL	1	50268-314	TABLET, FILM COATED	5 mg	ORAL	ANDA	17 sections
Finasteride	HUMAN PRESCRIPTION DRUG LABEL	1	50268-323	TABLET, FILM COATED	5 mg	ORAL	ANDA	17 sections
Finasteride	HUMAN PRESCRIPTION DRUG LABEL	1	50436-0089	TABLET, FILM COATED	1 mg	ORAL	ANDA	18 sections
Finasteride	HUMAN PRESCRIPTION DRUG LABEL	1	50436-0455	TABLET, COATED	1 mg	ORAL	ANDA	17 sections
Finasteride	HUMAN PRESCRIPTION DRUG LABEL	1	50436-0927	TABLET, FILM COATED	1 mg	ORAL	ANDA	17 sections
PROPECIA	HUMAN PRESCRIPTION DRUG LABEL	1	54868-4120	TABLET, FILM COATED	1 mg	ORAL	NDA	19 sections
Finasteride	HUMAN PRESCRIPTION DRUG LABEL	1	54868-5636	TABLET, FILM COATED	5 mg	ORAL	ANDA	12 sections
Finasteride	HUMAN PRESCRIPTION DRUG LABEL	1	55111-171	TABLET, FILM COATED	1 mg	ORAL	ANDA	17 sections
Finasteride	HUMAN PRESCRIPTION DRUG LABEL	1	55111-172	TABLET	5 mg	ORAL	ANDA	18 sections
Finasteride	HUMAN PRESCRIPTION DRUG LABEL	1	55154-8083	TABLET, FILM COATED	5 mg	ORAL	ANDA	17 sections
Finasteride	HUMAN PRESCRIPTION DRUG LABEL	1	57237-061	TABLET, FILM COATED	1 mg	ORAL	ANDA	17 sections